Healthcare Demand Upgrade, EPS Creative Health Technology Group (3860.HK) Expands Its Healthcare Business

HONG KONG, July 24, 2026 - (JCN Newswire via SeaPRwire.com) - As Asia’s demographic structure evolves and health awareness continues to rise, the healthcare market is undergoing sustained upgrading. Demand across high-end medical services, health and wellness products, and pharmaceutical R&D support is steadily increasing. Against this backdrop, EPS Creative Health…

Global New Material International’s Cross-border Acquisition Was Selected by the Hong Kong Department of Justice as a Benchmark Case of Going Global, Further Enhancing the Value of Its Global Platform

EQS via SeaPRwire.com / 24/07/2026 / 15:23 UTC+8 In the capital markets, being recognized as a model case by an official authority is in itself a powerful endorsement and recognition. In July 2026, the Hong Kong Department of Justice published the Collection of Success Stories: Hong Kong's Professional Services Supporting…

The Scarce Target of Bank-Owned Investment Banking Platforms – The Shareholder Synergy and Strategic Positioning Value of CMBC Capital

HONG KONG, July 24, 2026 - (ACN Newswire via SeaPRwire.com) - In the Hong Kong Chinese-funded investment banking sector, CMBC Capital Holdings Limited (01141.HK) is a sample worth independent examination. As a Stock Connect target with a historical peak market capitalization of HK$30 billion, it is not a traditional broker relying…

The Resonance of High Dividends and Prudent Capital Management: Defensive Value Revaluation of CMBC Capital (1141.HK)

HONG KONG, July 24, 2026 - (ACN Newswire via SeaPRwire.com) - In the persistently volatile macro environment of the Hong Kong stock market, asset security and cash return capacity have become core considerations for capital allocation. CMBC Capital (1141.HK), with its robust capital adequacy ratio, prudent financial policies, and attractive dividend…

CT ENTERPRISE Rebrands as CPBIO: Company completes transition to a biotech-driven business, positioning itself as an integrated life sciences platform

EQS via SeaPRwire.com / 24/07/2026 / 08:35 UTC+8 [For Immediate Release]                                                      24 July 2026     CPBIO HOLDING COMPANY LIMITED 正大生物控股有限公司 (Incorporated in Bermuda with members’ limited liability) (Stock code: 03839.HK)   CT ENTERPRISE Rebrands as CPBIOCompany completes transition to a biotech-driven business, positioning itself as an integrated life…